Approval for patients at intermediate-high, high-risk for recurrence post-nephrectomy The U.S. Food and Drug Administration approved pembrolizumab for the adjuvant treatment of patients with renal cell carcinoma (RCC) who are at...
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — Cyclic fasting or fasting-mimicking diet (FMD)...
Cervical cancer incidence cut by nearly 90% in girls offered shots at age 12-13 years England’s human papillomavirus (HPV) vaccination program has nearly eliminated cervical cancer in young women, with rates of cervical cancer...
But FDG-PET/CT has limited value Adding staging laparoscopy (SL) to staging of locally advanced gastric cancer was found to have a significant and clinically relevant added value in the staging of peritoneal or locally...
Upon completion of the educational activity, participants should be able to: Discuss a study that...
“Racial inequity in healthcare delivery and outcomes in the United States is well-documented, and...
Unplanned acute care continues to be a major contributor to growing healthcare costs in the United...
Patients with epithelial ovarian cancer most commonly present when their disease has reached an...
The first targeted treatment for this population requires Dx with an FDA-approved test The FDA granted intravenous amivantamab-vmjw (Rybrevant) accelerated approval for adult patients with non-small cell lung cancer with...
Patients with rare blood disease can access drug through REMS The FDA approved subcutaneous pegcetacoplan (Empaveli) for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disease that affects 1-1.5...
CAC score may guide breast ca Tx and CVD prevention The risk of cardiovascular disease, particularly coronary artery disease, among breast cancer survivors is well-known, but a study from Dutch researchers suggests that CT scans...
This course discusses a meta-analysis of the most reported and discussed risk factors for venous...
